These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7760853)

  • 1. The dominant negative effect of thyroid hormone receptor splicing variant alpha 2 does not require binding to a thyroid response element.
    Liu RT; Suzuki S; Miyamoto T; Takeda T; Ozata M; DeGroot LJ
    Mol Endocrinol; 1995 Jan; 9(1):86-95. PubMed ID: 7760853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An artificial thyroid hormone receptor mutant without DNA binding can have dominant negative effect.
    Liu RT; Suzuki S; Takeda T; DeGroot LJ
    Mol Cell Endocrinol; 1996 Jun; 120(1):85-93. PubMed ID: 8809742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The function of retinoid X receptors on negative thyroid hormone response elements.
    Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ
    Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
    Piedrafita FJ; Ortiz MA; Pfahl M
    Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
    Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
    Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
    Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
    J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma.
    Lin KH; Zhu XG; Hsu HC; Chen SL; Shieh HY; Chen ST; McPhie P; Cheng SY
    Endocrinology; 1997 Dec; 138(12):5308-15. PubMed ID: 9389515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors.
    Wu Y; Yang YZ; Koenig RJ
    Mol Endocrinol; 1998 Oct; 12(10):1542-50. PubMed ID: 9773977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.
    Collingwood TN; Adams M; Tone Y; Chatterjee VK
    Mol Endocrinol; 1994 Sep; 8(9):1262-77. PubMed ID: 7838159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant negative activity of an endogenous thyroid hormone receptor variant (alpha 2) is due to competition for binding sites on target genes.
    Katz D; Lazar MA
    J Biol Chem; 1993 Oct; 268(28):20904-10. PubMed ID: 8407924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
    Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
    Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone receptor monomer, homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide sequences in thyroid hormone response elements.
    Ikeda M; Rhee M; Chin WW
    Endocrinology; 1994 Oct; 135(4):1628-38. PubMed ID: 7925126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
    Zavacki AM; Harney JW; Brent GA; Larsen PR
    Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoid-X receptor (RXR) differentially augments thyroid hormone response in cell lines as a function of the response element and endogenous RXR content.
    Hsu JH; Zavacki AM; Harney JW; Brent GA
    Endocrinology; 1995 Feb; 136(2):421-30. PubMed ID: 7835272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line.
    Lin KH; Zhu XG; Shieh HY; Hsu HC; Chen ST; McPhie P; Cheng SY
    Endocrinology; 1996 Oct; 137(10):4073-81. PubMed ID: 8828459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thyroid hormone receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors.
    Tagami T; Kopp P; Johnson W; Arseven OK; Jameson JL
    Endocrinology; 1998 May; 139(5):2535-44. PubMed ID: 9564869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
    Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
    Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
    Kitajima K; Nagaya T; Jameson JL
    Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L; Forrest D; Haugen BR; Wood WM; Curran T
    Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.